Article
Alteration of the fragile histidine triad gene in intrahepatic cholangiocarcinoma.
European journal of gastroenterology & hepatology - 1 Aug 2003
Koch Eileen, Fiedler Wolfgang, Tannapfel Andrea, Ballhausen Wolfgang G
Abstract excerpt
BACKGROUND AND AIMS: Intrahepatic cholangiocarcinoma is the second most common intrahepatic neoplasm, accounting for 10-30% of primary liver cancers. Since little is known about the development of this cancer, we searched for alterations to the fragile histidine triad (FHIT) gene, a putative tumo...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
